MedPath

Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Registration Number
NCT00002904
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase I trial to study the effectiveness of ecteinascidin 743 in treating adults with advanced solid tumors.

Detailed Description

OBJECTIVES: I. Estimate the maximum tolerated dose (MTD) of ecteinascidin-743 (ET-743) when administered as a single intravenous infusion every 21 days in adults with solid tumors not amenable to standard therapy. II. Describe the qualitative and quantitative toxic effects of ET-743, and study the predictability, duration, intensity, onset, reversibility, and dose-relationship of these toxic effects in these patients. III. Propose a safe dose for a phase II study based on the MTD determined on this study. IV. Assess the pharmacokinetics of ET-743 at different dose levels. V. Document any antitumor effects of ET-743 in these patients.

OUTLINE: This is a multicenter study. All patients receive ET-743 IV over 3 hours every 21 days for 4 courses. Treatment continues in the absence of disease progression or unacceptable toxicity. Cohorts of 3-6 patients receive escalating doses of ET-743 until the maximum tolerated dose is determined. Patients are followed at 1 month, then every 3 months until disease progression.

PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study over 12 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (49)

Centre Oscar Lambret

🇫🇷

Lille, France

Martin Luther Universitaet

🇩🇪

Halle Saale, Germany

Universitats-Krankenhaus Eppendorf

🇩🇪

Hamburg, Germany

Rambam Medical Center

🇮🇱

Haifa, Israel

Academisch Ziekenhuis der Vrije Universiteit

🇳🇱

Amsterdam, Netherlands

Antoni van Leeuwenhoekhuis

🇳🇱

Amsterdam, Netherlands

St. Radboud University Hospital

🇳🇱

Nijmegen, Netherlands

Instituto Portugues de Oncologia de Francisco Gentil

🇵🇹

Lisbon, Portugal

University Hospital

🇨🇭

Basel, Switzerland

Ospedale San Giovanni

🇨🇭

Bellinzona, Switzerland

Royal Marsden NHS Trust

🇬🇧

London, England, United Kingdom

Medizinische Hochschule Hannover

🇩🇪

Hannover, Germany

Kantonsspital - Saint Gallen

🇨🇭

Saint Gallen, Switzerland

U.Z. Gasthuisberg

🇧🇪

Leuven, Belgium

Centre Eugene Marquis

🇫🇷

Rennes, France

Hopital Paul Brousse

🇫🇷

Villejuif, France

Klinikum Nurnberg

🇩🇪

Nuremberg (Nurnberg), Germany

Schneider Children's Medical Center of Israel

🇮🇱

Petah-Tikva, Israel

Centre Jean Perrin

🇫🇷

Clermont-Ferrand, France

CHU de la Timone

🇫🇷

Marseille, France

CRLCC Nantes - Atlantique

🇫🇷

Nantes-Saint Herblain, France

Institut Gustave Roussy

🇫🇷

Villejuif, France

University of Ioannina

🇬🇷

Ioannina, Greece

Centro di Riferimento Oncologico - Aviano

🇮🇹

Aviano, Italy

Herlev Hospital - University Hospital of Copenhagen

🇩🇰

Herlev, Denmark

Institut Curie - Section Medicale

🇫🇷

Paris, France

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Istituti Fisioterapici Ospitalieri - Roma

🇮🇹

Rome, Italy

Norwegian Radium Hospital

🇳🇴

Oslo, Norway

San Raffaele Hospital

🇮🇹

Rome, Italy

Rotterdam Cancer Institute

🇳🇱

Rotterdam, Netherlands

Rigshospitalet

🇩🇰

Copenhagen, Denmark

Ludwig Boltzmann - Institute for Applied Cancer Research

🇦🇹

Vienna (Wien), Austria

Institut Jules Bordet

🇧🇪

Brussels (Bruxelles), Belgium

Universitair Ziekenhuis Antwerpen

🇧🇪

Edegem, Belgium

Institut Bergonie

🇫🇷

Bordeaux, France

Centre Leon Berard

🇫🇷

Lyon, France

Centre Georges-Francois Leclerc

🇫🇷

Dijon, France

Istituto Nazionale per lo Studio e la Cura dei Tumori

🇮🇹

Naples (Napoli), Italy

Centre Alexis Vautrin

🇫🇷

Vandoeuvre-les-Nancy, France

Centre Henri Becquerel

🇫🇷

Rouen, France

Istituto Europeo Di Oncologia

🇮🇹

Milano, Italy

Institut Claudius Regaud

🇫🇷

Toulouse, France

Academisch Ziekenhuis Groningen

🇳🇱

Groningen, Netherlands

Western General Hospital

🇬🇧

Edinburgh, Scotland, United Kingdom

Inselspital, Bern

🇨🇭

Bern, Switzerland

Clinique De Genolier

🇨🇭

Genolier, Switzerland

Newcastle General Hospital

🇬🇧

Newcastle Upon Tyne, England, United Kingdom

Beatson Oncology Centre

🇬🇧

Glasgow, Scotland, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath